Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital by A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina

Get full text

Pharmacoeconomic analysis of Flemoclav Solutab® use in adult patients with acute sinusitis in routine outpatient clinical practice in Russia by A. S. Kolbin, I. A. Vilum, M. A. Proskurin, Yu. E. Balykina

Get full text

PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD by A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin

Get full text

Health technology assessment of colorectal cancer chemotherapy with afl ibercept by A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin

Get full text

PHARMACOECONOMIC ANALYSIS OF MICAFUNGIN USING IN THE TREATMENT OF INVASIVE CANDIDIASIS IN NEWBORNS by A.S. Kolbin, M.A. Proskurin, Yu.A. Balykina, N.N. Klimko

Get full text

Pharmacoeconomic evaluation of ipragliflozin in combination with metformin in comparison with other regimens of therapy for type 2 diabetes mellitus by A. S. Kolbin, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin

Get full text

HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE by A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina

Get full text

PHARMACOECONOMIC ANALYSIS OF MICAFUNGIN USING IN THE TREATMENT OF INVASIVE CANDIDIASIS IN NEWBORNS by A.S. Kolbin, M.A. Proskurin, Yu.A. Balykina, N.N. Klimko

Get full text

Health technology assessment of hyaluronans in osteoarthritis treatment by A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin

Get full text

Pharmacoeconomic analysis of botulinum toxin in complex therapy for cerebral palsy by A. S. Kolbin, I. A. Vilum, M. A. Proskurin, Yu. E. Balykina

Get full text

Pharmacoeconomic analysis of vemurafenib and dabrafenib use in patients with inoperable or metastatic melanoma with BRAF V600 mutation by A. S. Kolbin, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin

Get full text

Pharmacoeconomic analysis of the use of botulinum toxin in the treatment of poststroke spasticity by A. S. Kolbin, I. A. Vilum, M. A. Proskurin, Yu. E. Balykina

Get full text

The clinical-economic characteristic of current basis-bolus insulin therapy schemes in diabetes mellitus type 1 in adults by A. S. Kolbin, A. A. Kurilev, Y. E. Balikina, M. A. Proskurin

Get full text

BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD by A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina

Get full text

Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study by A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Yu. E. Balykina

Get full text

An update of pharmacoeconomic analysis of trastuzumab emtanzine in patients with HER2+ breast cancer and central nervous system metastases by A. S. Kolbin, A. A. Kurylev, Y. E. Balykina, M. A. Proskurin

Get full text

Pharmacoeconomic analysis of fixed-duration targeted therapy regimens for chronic lymphocytic leukemia compared with therapy used until progression or intolerable toxicity by A. R. Kasimova, A. S. Kolbin, M. A. Proskurin, Yu. E. Balykina

Get full text

Pharmacoeconomic analysis of the use of ibrutinib in therapy of the first line of a chronic lymphocytic leukaemia for patients with 17p deletion by A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin

Get full text

Pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases by A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina

Get full text

Clinical-economic analysis of the target therapy in severe atopic dermatitidis in adults by A. S. Kolbin, Y. M. Gomon, M. A. Proskurin, Y. E. Balikina

Get full text